New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 2, 2014
12:49 EDTAGENAgenus price target lowered to $6 from $11 at Maxim
Maxim views the data that Agenus announced for its Heat Shock Protein Vaccine as positive however, but also thinks the company is now likely to seek a partnership to support a pivotal trial. The firm, which previously thought Agenus might be in a position to file for approval with phase II data, lowered its price target on the stock to $6 but keeps its Buy rating on the name.
News For AGEN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 10, 2014
16:18 EDTAGENAgenus files $150M mixed securities shelf

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use